Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.

Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Abstract Text:

    shih-jen tsaiShih-Jen Tsai,

    Major depressive disorder (MDD) is a common mental disease, but with an unknown etiology. Antidepressants are the main biological treatment for MDD. However, current antidepressive agents have a slow onset of effect and a substantial proportion of MDD patients do not clinically improve, despite maximal medication. Thus, the exploration for new antidepressants with novel strategies may help to develop faster and more effective antidepressant agents. Studies in the recent decades have demonstrated that antidepressants increase central brain-derived neurotrophic factor (BDNF) levels and activating the BDNF-signaling pathway may play an important role in their therapeutic mechanism. Cysteamine is a natural product of cells and constitutes the terminal region of the CoA molecule. Recent work has found that cysteamine and a related agent, cystamine, have neuroprotective effects in Huntington's disease (HD) mice, through enhancing central BDNF levels. Furthermore, cystamine or cysteamine injection could increase serum BDNF levels in wild-type mice as well as HD mice. Since activation of the BDNF-dependent pathway plays an important role in the mechanism of antidepressant therapeutic action, cystamine or its derivatives could have potential antidepressant therapeutic effects. Among these agents, pantethine may be one of the most promising agents. It is a naturally occurring compound which can be administered orally with negligible side effects, and is metabolized to cysteamine. Further evaluation of the therapeutic and toxic effects of these cysteamine-related antidepressant agents in MDD animal models is needed before any clinical application.

    Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Publishing Authors By Initials

    sj tsaiSJ Tsai,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Medical hypotheses

    VOLUME: 67

    Page Numbers: 1185-8

    Journal Abbreviation:

    ISSN: 0306-9877

    DAY: 22

    MONTH: 06

    YEAR: 2006

    Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7505668

    Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.

    AFFILIATION: Department of Psychiatry, Taipei Veterans General Hospital, Taiwan; Division of Psychiatry, School of Medicine, National Yang-Ming University, Taiwan.

    Country: Scotland

    Scotland Research PublicationScotland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Med Hypotheses

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News